Gyre Therapeutics (GYRE) FCF Margin (2010 - 2026)
Gyre Therapeutics' FCF Margin came in at -58.44% for Q2 2026, down 32.18 percentage points from -26.26% a year earlier and down 71.86 percentage points from the prior quarter.
Powered by 
Analysis
Gyre Therapeutics (GYRE) FCF Margin (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gyre Therapeutics reported FCF Margin of -5.12%, up 4.13 percentage points year-over-year; for FY2025, it was -0.15%, up 5.48 percentage points from FY2024.
- FCF Margin carries a five-year change of +262.63 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -5.63% in FY2024 (-20.95 pp), 15.32% in FY2023 (+9.75 pp), 5.56% in FY2022 (+1158.39 pp) and -1152.82% in FY2021 (-890.04 pp).
- The Q2 2026 figure represents the lowest quarterly FCF Margin since Q1 2022.
- Year-over-year, FCF Margin increased in three of the last eight quarters, with an average year-over-year change of -2.43 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q1 2023 (a gain of 1552.43 percentage points), and the weakest in Q4 2023 (a drop of 37.86 percentage points).
- Business Quant data shows GYRE's FCF Margin at 13.42% (Q1 2026), -15.51% (Q4 2025) and 44.66% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 30.39% |
| 10 | Gyre Therapeutics | 777.23 Mn | 579.94 Mn | 26.90 Mn | -58.44% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -58.44% |
| Mar 31, 2026 | 13.42% |
| Dec 31, 2025 | -15.51% |
| Sep 30, 2025 | 44.66% |
| Jun 30, 2025 | -26.26% |
| Mar 31, 2025 | -1.14% |
| Dec 31, 2024 | -9.66% |
| Sep 30, 2024 | 4.05% |
| Jun 30, 2024 | -27.55% |
| Mar 31, 2024 | 9.76% |
| Dec 31, 2023 | 3.82% |
| Sep 30, 2023 | 17.50% |
| Jun 30, 2023 | 7.01% |
| Mar 31, 2023 | 34.80% |
| Dec 31, 2022 | 41.67% |
| Mar 31, 2022 | -1,517.63% |
| Dec 31, 2021 | -724.43% |
| Sep 30, 2021 | -960.94% |
| Jun 30, 2021 | -1,777.65% |
| Mar 31, 2021 | -1,660.26% |
API Access
Gyre Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=GYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "GYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=GYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();